Japan Diabetes Mellitus Effective Network System Study
Not Applicable
Recruiting
- Conditions
- Type 2 Diabetes mellitus
- Registration Number
- JPRN-UMIN000018459
- Lead Sponsor
- ational Hospital Organization, Kyoto Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1500
Inclusion Criteria
Not provided
Exclusion Criteria
1) Secondary obesity associated with endocrine disorders. 2) Severe liver dysfunction and liver cirrhosis. 3) Severe renal dysfunction (serum creatinine >= 2.0mg/dl). 4) Patients who are pregnant. 5) Subjects judged by the investigator/project lead to be ineligible for other reasons.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways does J-DEFENS study to improve Type 2 Diabetes management in Japan?
How does the J-DEFENS observational study compare to standard-of-care therapies like metformin or SGLT2 inhibitors?
Which biomarkers are associated with treatment response in the J-DEFENS Type 2 Diabetes cohort?
What adverse events were reported in the J-DEFENS study and how do they align with GLP-1 agonist risks?
How does the J-DEFENS network system approach compare to global diabetes registries like the UK Biobank?